Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Bruker (BRKR) over the last 17 years, with Q3 2025 value amounting to $33.3 million.

  • Bruker's Gains from Investment Securities fell 5166.91% to $33.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.6 million, marking a year-over-year increase of 50600.0%. This contributed to the annual value of $48.3 million for FY2024, which is 25046.73% up from last year.
  • As of Q3 2025, Bruker's Gains from Investment Securities stood at $33.3 million, which was down 5166.91% from $11.6 million recorded in Q2 2025.
  • Bruker's 5-year Gains from Investment Securities high stood at $68.9 million for Q3 2024, and its period low was -$51.4 million during Q4 2023.
  • Its 5-year average for Gains from Investment Securities is $4.3 million, with a median of $6.9 million in 2024.
  • The largest annual percentage gain for Bruker's Gains from Investment Securities in the last 5 years was 120740.74% (2023), contrasted with its biggest fall of 36494.85% (2023).
  • Quarter analysis of 5 years shows Bruker's Gains from Investment Securities stood at -$3.2 million in 2021, then skyrocketed by 706.25% to $19.4 million in 2022, then tumbled by 364.95% to -$51.4 million in 2023, then skyrocketed by 113.42% to $6.9 million in 2024, then skyrocketed by 382.61% to $33.3 million in 2025.
  • Its Gains from Investment Securities stands at $33.3 million for Q3 2025, versus $11.6 million for Q2 2025 and -$11.2 million for Q1 2025.